Ramesh Mazhari is a Cardiology physician affiliated with George Washington University Hospital. OpenAlex indexes 66 publications with 1,556 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2150 Pennsylvania Ave NW
Washington, DC 200373201
Telephone
202-215-7104Registry record last updated 22 Apr 2013.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202543 payments$11,588openpaymentsdata.cms.gov ↗
- ABIOMEDProgram year202516 payments
- Abbott LaboratoriesProgram year202514 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73%Statin22.6%Atorvastatin Calcium58%Rosuvastatin Calcium36%Simvastatin5%Part D<11 patientsBeta blocker15.6%Metoprolol Succinate74%Carvedilol26%Part D≥40 patients+ 10 more classes in this area
Blood & clotting
16.4%P2Y12 inhibitor10%Clopidogrel79%Prasugrel Hcl21%Part D<11 patientsFactor Xa inhibitor6.4%Eliquis73%Xarelto28%Part D<11 patientsMetabolism & gastrointestinal
9.5%SGLT2 inhibitor9.5%Jardiance100%Part D≥31 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Life’s Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast Cancer
JACC CardioOncology
2024 - RNAseq of INOCA patients identifies innate, invariant, and acquired immune changes: potential autoimmune microvascular dysfunction
Frontiers in Cardiovascular Medicine
2024 - ASSOCIATIONS BETWEEN LIFE'S ESSENTIAL 8 AND INCIDENT CARDIOVASCULAR EVENTS IN POSTMENOPAUSAL BREAST CANCER SURVIVORS
Journal of the American College of Cardiology
2024 - LVAD OUTFLOW GRAFT OBSTRUCTION: RARE BUT TREATABLE COMPLICATION
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Keith Wroblewski, MD
George Washington University Hospital
Jalil Ahari, MD
George Washington University Hospital
Lynt Johnson, MD
George Washington University Hospital
Danielle Davison, MD
George Washington University Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”